Stride (Stride Health Group) is a Norwich-based preventative health company offering a diagnostics-driven membership, StrideOne, that combines DNA, blood and gut-microbiome testing with practitioner-led interpretation, targeted supplements and personalised action plans. Founded in 2024 by Andrew Steele, a former Team GB 400m runner and co-founder of DNAfit (sold to Prenetics in 2018), it reports 85% member retention over its first 13 months and more than 16,000 customers, and is expanding into the US and premium wellness partnerships.
1
Round
1
Industry
4
Tags
Oct 14, 2026
Latest raise
Funding activity · 1 round
Oct 14, 2026
GBP 4.6M
Seed
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
